Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. more
Time Frame | MLAB | Sector | S&P500 |
---|---|---|---|
1-Week Return | 10.26% | 2.43% | 1.57% |
1-Month Return | 0.51% | -2.15% | 3.19% |
3-Month Return | -17.52% | -6.42% | 6.57% |
6-Month Return | -0.55% | 1.91% | 12.75% |
1-Year Return | 31.44% | 11.57% | 31.51% |
3-Year Return | -63.68% | 10.17% | 30.11% |
5-Year Return | -52.45% | 46.25% | 90.82% |
10-Year Return | 56.46% | 111.45% | 189.07% |
Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 117.69M | 133.94M | 184.34M | 219.08M | 216.19M | [{"date":"2020-03-31","value":53.72,"profit":true},{"date":"2021-03-31","value":61.14,"profit":true},{"date":"2022-03-31","value":84.14,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":98.68,"profit":true}] |
Cost of Revenue | 52.75M | 46.92M | 75.25M | 85.39M | 82.94M | [{"date":"2020-03-31","value":61.78,"profit":true},{"date":"2021-03-31","value":54.95,"profit":true},{"date":"2022-03-31","value":88.12,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":97.13,"profit":true}] |
Gross Profit | 64.93M | 87.01M | 109.09M | 133.69M | 133.25M | [{"date":"2020-03-31","value":48.57,"profit":true},{"date":"2021-03-31","value":65.08,"profit":true},{"date":"2022-03-31","value":81.6,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":99.67,"profit":true}] |
Gross Margin | 55.17% | 64.97% | 59.18% | 61.02% | 61.64% | [{"date":"2020-03-31","value":84.93,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":91.09,"profit":true},{"date":"2023-03-31","value":93.93,"profit":true},{"date":"2024-03-31","value":94.87,"profit":true}] |
Operating Expenses | 57.14M | 74.66M | 104.39M | 130.37M | 406.55M | [{"date":"2020-03-31","value":14.05,"profit":true},{"date":"2021-03-31","value":18.36,"profit":true},{"date":"2022-03-31","value":25.68,"profit":true},{"date":"2023-03-31","value":32.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
Operating Income | (4.90M) | (5.30M) | (20.37M) | (30.50M) | (272.07M) | [{"date":"2020-03-31","value":-490000000,"profit":false},{"date":"2021-03-31","value":-530200000,"profit":false},{"date":"2022-03-31","value":-2036600000,"profit":false},{"date":"2023-03-31","value":-3050400000,"profit":false},{"date":"2024-03-31","value":-27207500000,"profit":false}] |
Total Non-Operating Income/Expense | 3.79M | (17.97M) | (5.01M) | (8.48M) | (9.27M) | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-474.32,"profit":false},{"date":"2022-03-31","value":-132.3,"profit":false},{"date":"2023-03-31","value":-223.78,"profit":false},{"date":"2024-03-31","value":-244.66,"profit":false}] |
Pre-Tax Income | 3.43M | 2.30M | 3.57M | (389.00K) | (275.65M) | [{"date":"2020-03-31","value":96.05,"profit":true},{"date":"2021-03-31","value":64.44,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-10.88,"profit":false},{"date":"2024-03-31","value":-7712.59,"profit":false}] |
Income Taxes | 2.08M | (971.00K) | 1.70M | (1.32M) | (21.40M) | [{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-46.59,"profit":false},{"date":"2022-03-31","value":81.72,"profit":true},{"date":"2023-03-31","value":-63.29,"profit":false},{"date":"2024-03-31","value":-1026.97,"profit":false}] |
Income After Taxes | 1.35M | 3.27M | 1.87M | 930.00K | (254.25M) | [{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}] |
Income From Continuous Operations | 1.35M | 3.27M | 1.87M | 930.00K | (254.25M) | [{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}] |
Net Income | 1.35M | 3.27M | 1.87M | 930.00K | (254.25M) | [{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}] |
EPS (Diluted) | 0.84 | 0.58 | 1.35 | 0.16 | 3.76 | [{"date":"2020-03-31","value":22.34,"profit":true},{"date":"2021-03-31","value":15.43,"profit":true},{"date":"2022-03-31","value":35.9,"profit":true},{"date":"2023-03-31","value":4.26,"profit":true},{"date":"2024-03-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
MLAB | |
---|---|
Cash Ratio | 0.16 |
Current Ratio | 0.70 |
Quick Ratio | 0.51 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MLAB | |
---|---|
ROA (LTM) | 1.69% |
ROE (LTM) | -89.46% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MLAB | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.64 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.36 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MLAB | |
---|---|
Trailing PE | NM |
Forward PE | 35.21 |
P/S (TTM) | 2.70 |
P/B | 3.82 |
Price/FCF | 177 |
EV/R | 3.57 |
EV/Ebitda | 305.65 |
PEG | NM |
Mesa Laboratories Inc (MLAB) share price today is $113.9
Yes, Indians can buy shares of Mesa Laboratories Inc (MLAB) on Vested. To buy Mesa Laboratories Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MLAB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Mesa Laboratories Inc (MLAB) via the Vested app. You can start investing in Mesa Laboratories Inc (MLAB) with a minimum investment of $1.
You can invest in shares of Mesa Laboratories Inc (MLAB) via Vested in three simple steps:
The 52-week high price of Mesa Laboratories Inc (MLAB) is $141. The 52-week low price of Mesa Laboratories Inc (MLAB) is $83.58.
The price-to-earnings (P/E) ratio of Mesa Laboratories Inc (MLAB) is
The price-to-book (P/B) ratio of Mesa Laboratories Inc (MLAB) is 3.82
The dividend yield of Mesa Laboratories Inc (MLAB) is 0.56%
The market capitalization of Mesa Laboratories Inc (MLAB) is $617.12M
The stock symbol (or ticker) of Mesa Laboratories Inc is MLAB